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EDITORIAL
Preoperative  Aerobic  Capacity  --  Is There  a Role  for
Routine Evaluation  in  Liver Transplantation?
Capacidade  Aeróbia  Pré-operatória  --  Existe  um  Papel  para  a  Avaliac¸ão da
Rotina  no  Transplante  de  Fígado?
Patrícia Andrade, Susana Lopes ∗Gastroenterology  Department,  Centro  Hospitalar  de  São  João,  Porto,  Portugal
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pEnd-stage  liver  disease  is  a  systemic  condition  leading  to
multiple  visceral  and  metabolic  disorders.  Regardless  of  liver
cirrhosis  etiology,  its  5-year  mortality  reaches  85%  with-
out  liver  transplantation  (LT).1 The  occurrence  of  a  major
complication  is  an  important  turning  point  in  the  natural
history  of  the  disease;  it  is  predictive  of  decreased  survival
and  should  prompt  discussion  about  the  optimal  timing  for
LT.  Given  the  discrepancy  between  the  increasing  number  of
candidates  and  the  limited  availability  of  liver  grafts,  there
is  a  need  to  identify  patients  most  likely  to  beneﬁt  from
LT.
In  comparison  with  other  surgical  procedures,  liver  trans-
plantation  has  a  signiﬁcant  mortality  rate  in  the  early
post-transplant  period.  Early  post-transplant  mortality  is
both  related  to  patient’s  pre-transplant  condition  and  to  the
quality  of  the  donor  organ.  Clinical  scoring  systems,  such
as  Child--Pugh--Turcotte  (CPT)  classiﬁcation  and  Model  for
End-Stage  Liver  Disease  (MELD)  score,  have  been  developed
to  better  evaluate  the  severity  of  preoperative  liver  dis-
ease,  but  they  do  not  consistently  predict  post-transplant
survival.2
It  has  been  increasingly  recognized  that  patients  with
chronic  liver  disease  (CLD)  develop  progressive  impairment
of  their  ﬁtness  and  exercise  capacity.3--5 There  are  a  number
of  potential  mechanisms  that  explain  the  reduced  exercise∗ Corresponding author.
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cterized  by  a  shift  in  oxidative  fuels  from  glucose  to  lipid  to
ustain  exercise  in  cirrhotic  patients;  (ii)  malnutrition,  mus-
le  wasting,  and  muscle  weakness  that  are  present  in  more
han  a  half  of  these  patients;  (iii)  cirrhotic  cardiomyopathy,
 chronic  cardiac  dysfunction  related  to  liver  cirrhosis,  and
nrelated  to  the  etiology  characterized  by  a  chronotropic
ncompetence  and  incapacity  to  reach  the  predicted  maxi-
al  cardiac  frequency;  (iv)  anemia,  found  in  up  to  75%  of
atients  in  transplant  waiting  list;  (v)  beta-blocker  therapy
hat  may  inhibit  the  adaptive  cardiac  response  to  ane-
ia,  resulting  in  a  synergic  deleterious  effect  on  maximal
xercise  capacity  and  (vi)  a  multifactorial  pulmonary  gas
xchange  impairment.3--6
Cardiopulmonary  exercise  testing  (CPET)  is  a  safe,  non-
nvasive,  and  dynamic  measure  that  represents  the  gold
tandard  for  the  determination  of  exercise  capacity  and
ardiorespiratory  reserve.  It  generates  measures  of  sev-
ral  aspects  of  aerobic  capacity  (AC),  which  is  the  ability
f  the  body  to  consume  and  use  oxygen  during  exercise.7
uring  CPET,  numerous  cardiac,  respiratory  and  metabolic
unctional  parameters  are  measured  while  the  workload  is
rogressively  increased  on  an  electronically  braked  cycle
rgometer  until  the  patient  is  exhausted.  The  evaluated
arameters  include  the  peak  oxygen  consumption  (VO2 peak)
chieved  during  testing  and  the  point  at  which  an  apparent
hift  occurs  from  aerobic  to  anaerobic  metabolism  [i.e.,  the
naerobic  threshold  (AT)]  that  is  often  reported  as  a  per-
entage  of  VO2 max  or  VO2 peak.  Together,  these  broadly
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ndicate  the  ability  of  the  cardiopulmonary  system  to  deliver
xygen  to  the  peripheral  tissues  and  the  ability  of  the  tissues
o  use  that  oxygen.3,5,7 Maximal  exercise  capacity  is  a  strong
nd  independent  predictor  of  death  from  any  cause.  Thus,
O2 peak  has  been  used  to  predict  the  risks  of  periopera-
ive  morbidity  and  mortality  and  to  select  good  candidates
or  lung  surgery,  heart  transplantation,  or  rehabilitation
rograms.3 Similarly,  recent  studies  have  also  shown  that
O2 peak  is  signiﬁcantly  lower  in  patients  with  CLD  and  sug-
ested  that  CPET  can  help  the  clinician  during  the  screening
rocess  to  accurately  identify  patients  at  high  risk  of  post-
T  mortality.6--9 Studies  suggest  that  CPET  is  the  only  test
hat  can  detect  early  all  presumed  contraindications  for  LT
ncluding  unstable  coronary  artery  disease,  severe  cirrhotic
ardiomyopathy,  and  porto-pulmonary  hypertension.3,5
Focusing  on  these  data,  in  this  issue  of  GE,  Mancuzo  et
l11 presented  a  study  assessing  the  association  between  AC,
iver  disease  severity  and  postoperative  LT  outcome  (length
f  ICU  stay,  length  of  hospitalization  and  postoperative  mor-
ality).  This  study  included  47  candidates  on  LT  waiting
ist  who  performed  CPET  tests  less  than  90  days  before  LT.
ELD  and  CPT  scores  were  calculated  to  assess  liver  dis-
ase  severity.  In  contrast  to  previous  studies,  Mancuzo  et
l  found  that  AC  measured  by  VO2 peak  was  comparable
o  that  of  healthy  sedentary  individuals.  These  differences
ay  be  explained  by  differences  in  disease  severity  of  the
irrhotic  patients  enrolled  in  previous  studies.  Indeed,  Man-
uzo  et  al  observed  that  patients  with  a  MELD  score  <18
ad  a  signiﬁcantly  higher  VO2 peak  compared  to  those  in
he  MELD  >  18  subgroup.  Similar  ﬁndings  were  observed  in
ther  studies  that  showed  a  negative  correlation  between
he  disease  severity  determined  either  by  MELD  score  or  CPT
lassiﬁcation  and  VO2 peak  values.2,10--12 Mancuzo  also  found
n  independent  association  between  AC  and  the  length  of
ospitalization,  a  similar  ﬁnding  to  that  of  Bernal  et  al12.
owever,  a  signiﬁcant  association  between  AC  and  ICU  stay
r  post-LT  mortality  was  not  established  in  the  present  study.
t  is  important  to  highlight  that  post-LT  mortality  was  too
mall  in  this  series,  which  can  explain  the  lack  of  association.
ll  three  previous  studies,  despite  some  limitations,  compar-
ng  pre-LT  exercise  capacity  with  post-LT  outcomes  found
igniﬁcant  independent  associations  between  the  preopera-
ive  VO2 peak  value  and  post-LT  survival.  Indeed,  in  a  study
f  Prentis  et  al  among  135  liver  transplant  candidates,  those
ith  greater  VO2 peak  (>60%  predicted  VO2 peak)  experi-
nced  better  12-month  survival  (87.5  ±  11%  vs  53.3  ±  12%,
 =  0.05)  and  in  another  recently  published  study,  VO2 at
entilatory  threshold  (<9  mL/min/kg  ideal  body  weight)  was
he  only  predictive  factor  of  mortality  after  LT.11,12 Exercise
apacity  may,  therefore,  be  a  prognostic  factor  for  post-LT
urvival.P.  Andrade,  S.  Lopes
A  precise  measure  of  VO2 during  exercise  would  be  espe-
ially  interesting  if  it  could  be  used  to  assess  post-LT  risk  of
eath,  to  gauge  ability  to  perform  physical  work,  and  to  sup-
ort  the  beneﬁt  of  well-conducted  rehabilitation  programs
n  the  pre-  and  post-LT  course.
Although  more  robust  data  will  be  needed  before  mak-
ng  speciﬁc  recommendations  about  a  routine  use  of  CPET
n  pre-LT  evaluation,  it  seems  that  CPET  provides  a  use-
ul  preoperative  tool  to  assess  the  global  health  status  of
T  candidates,  to  detect  their  comorbidities,  to  rule  out
ajor  contraindications  for  surgery,  and  eventually,  to  pre-
ict  their  post-operative  course.
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